{"id":3482,"date":"2020-01-20T16:45:09","date_gmt":"2020-01-20T21:45:09","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/"},"modified":"2026-09-24T00:08:47","modified_gmt":"2026-09-24T04:08:47","slug":"gensight-biologics-annonce-son-calendrier-financier-pour-2020","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/","title":{"rendered":"GenSight Biologics annonce son  calendrier financier pour 2020"},"content":{"rendered":"\n<strong>Paris, France, le 20 janvier 2020, 17h45 CET <\/strong>\u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e \u00e0 la d\u00e9couverte et au d\u00e9veloppement de th\u00e9rapies g\u00e9niques innovantes pour le traitement des maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2020.\n\n&nbsp;\n<table>\n<tbody>\n<tr>\n<td width=\"323\"><strong>Information<\/strong><\/td>\n<td width=\"278\"><strong>Date* <\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 4<sup>\u00e8me<\/sup> trimestre 2019<\/td>\n<td width=\"278\">21 janvier 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">R\u00e9sultats financiers annuels 2019<\/td>\n<td width=\"278\">12 mars 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 1<sup>er<\/sup> trimestre 2020<\/td>\n<td width=\"278\">21 avril 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Assembl\u00e9e G\u00e9n\u00e9rale des actionnaires<\/td>\n<td width=\"278\">29 avril 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">R\u00e9sultats financiers du 1<sup>er<\/sup> semestre 2020<\/td>\n<td width=\"278\">30 juillet 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 3<sup>\u00e8me<\/sup> trimestre 2020<\/td>\n<td width=\"278\">20 octobre 2020<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 4<sup>\u00e8me<\/sup> trimestre 2020<\/td>\n<td width=\"278\">19 janvier 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<em>* Ce calendrier financier est donn\u00e9 \u00e0 titre indicatif, sous r\u00e9serve de modifications. Le calendrier financier \u00e0 jour de la Soci\u00e9t\u00e9 est disponible sur son site Internet.<\/em>\n\n&nbsp;\n","protected":false},"excerpt":{"rendered":"<p>Paris, France, le 20 janvier 2020, 17h45 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e \u00e0 la d\u00e9couverte et au d\u00e9veloppement de th\u00e9rapies g\u00e9niques innovantes pour le traitement des maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2020. &nbsp; Information [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[],"news-type":[76,80],"post-year":[],"class_list":["post-3482","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-type-corporate","news-type-finance"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le 20 janvier 2020, 17h45 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e \u00e0 la d\u00e9couverte et au d\u00e9veloppement de th\u00e9rapies g\u00e9niques innovantes pour le traitement des maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2020. &nbsp; Information [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-20T21:45:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:08:47+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"GenSight Biologics annonce son calendrier financier pour 2020\",\"datePublished\":\"2020-01-20T21:45:09+00:00\",\"dateModified\":\"2026-09-24T04:08:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/\"},\"wordCount\":148,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/\",\"name\":\"GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-01-20T21:45:09+00:00\",\"dateModified\":\"2026-09-24T04:08:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/01\\\/20\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics annonce son calendrier financier pour 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics","og_description":"Paris, France, le 20 janvier 2020, 17h45 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e \u00e0 la d\u00e9couverte et au d\u00e9veloppement de th\u00e9rapies g\u00e9niques innovantes pour le traitement des maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2020. &nbsp; Information [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/","og_site_name":"GenSight Biologics","article_published_time":"2020-01-20T21:45:09+00:00","article_modified_time":"2026-09-24T04:08:47+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"GenSight Biologics annonce son calendrier financier pour 2020","datePublished":"2020-01-20T21:45:09+00:00","dateModified":"2026-09-24T04:08:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/"},"wordCount":148,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/","name":"GenSight Biologics annonce son calendrier financier pour 2020 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2020-01-20T21:45:09+00:00","dateModified":"2026-09-24T04:08:47+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/01\/20\/gensight-biologics-annonce-son-calendrier-financier-pour-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics annonce son calendrier financier pour 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=3482"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3482\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=3482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=3482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=3482"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=3482"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=3482"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=3482"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=3482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}